Daiichi Sankyo, Inc.

About Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc. is a global pharmaceutical company headquartered in the UK, dedicated to the research, development, and commercialization of innovative medicines. With a strong commitment to improving patient outcomes, the company focuses on several therapeutic areas, including oncology, cardiovascular diseases, and infectious diseases.

Founded in 2005, Daiichi Sankyo has rapidly expanded its presence in the global market, leveraging cutting-edge technology and scientific expertise. The company aims to address unmet medical needs through its robust pipeline of new drugs and therapies.

Core Activities:

• Research and Development: Investing heavily in R&D to discover new treatments.
• Manufacturing: Utilizing state-of-the-art facilities to produce high-quality pharmaceuticals.
• Commercialization: Bringing innovative products to market to enhance patient care.

Daiichi Sankyo is also committed to sustainability and corporate social responsibility, actively engaging in initiatives that promote health and well-being in communities worldwide. The company collaborates with healthcare professionals, researchers, and other stakeholders to foster innovation and improve access to medicines.

With a diverse workforce and a culture of collaboration, Daiichi Sankyo encourages creativity and excellence among its employees. The company’s vision is to be a leader in the pharmaceutical industry, recognized for its contributions to healthcare and its dedication to patients.

As Daiichi Sankyo continues to grow, it remains focused on its mission to create a healthier future for people around the globe.